Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders
Open accessThe DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Abstract
Gut microbiota exert a pivotal influence on various functions including gastrointestinal (GI) motility, metabolism, nutrition, immunity, and the neuroendocrine system in the host. These effects are mediated by not only short-chain fatty acids produced by microbiota but also gut hormones and inflammatory signaling by enteroendocrine and immune cells under the influence of the microbiota. GI motility is orchestrated by the enteric nervous system and hormonal networks, and disturbance of GI motility plays an important role in the pathophysiology of functional gastrointestinal disorders (FGIDs). In this context, microbiota-associated mediators are considered to act on specific receptors, thus affecting the enteric nervous system and, subsequently, GI motility. Thus, the pathophysiology of FGIDs is based on alterations of the gut microbiota/gut hormone axis, which have crucial effects on GI motility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, it has been reported that gut resident commensals can produce hormone-like metabolites, such as the short chain fatty acids (SCFAs), as a consequence of the bacterial fermentation of dietary fibers in the large intestine [36].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · cited 1×
“In 1999, ghrelin was isolated from the stomach as the endogenous ligand of growth hormone secretagogue receptor 1a.(5) Ghrelin”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Self-citationden Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 2×
“Recently, much attention has been focused on gut microbiota, as it has become clear that alterations in the gut microenvironment are significantly involved in the pathophysiology of various diseases such as GI disease, metabolic syndrome, autoimmune disease, and nervous/ endocrine system disorders.(2) Gut microbiota h…”
BackgroundIndigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Drossman, D. A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.032 · Cited by 2,430
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Psychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Peng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651 · cited 1×
“whereas GPR43, but not GPR41, also couples efficiently through the Gq protein family.(108) In the ileum and colon, GPR41 and GPR43 are expressed in enteroendocrine L-cells that secrete GLP-1 and PYY.”
BackgroundStanghellini, V., Chan, F. K. L., Hasler, W. L., Malagelada, J. R., Suzuki, H., Tack, J., & Talley, N. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.011 · Cited by 1,572
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.005 · Cited by 1,034
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 997
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939 · cited 17×
“On the other hand, since IBS and FD frequently overlap, it is not unlikely that endocrine cells may be altered in the upper GI in IBS.”
BackgroundInfluentialGhrelin Stimulates Gastric Acid Secretion and Motility in Rats
Masuda, Y., Tanaka, T., Inomata, N., Ohnuma, N., Tanaka, S., Itoh, Z., Hosoda, H., Kojima, M., & Kangawa, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3568 · Cited by 884
Deacon, C. F., Nauck, M. A., Toft-Nielsen, M., Pridal, L., Willms, B., & Holst, J. J. (1995) · Diabetes · doi:10.2337/diab.44.9.1126 · Cited by 878
Scavenger receptors in homeostasis and immunity
Canton, J., Neculai, D., & Grinstein, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3515 · Cited by 838 · cited 2×
“Furthermore, it has been reported that serotonin plays a role in polarization of macrophages toward an M2 phenotype.(160,162) Supporting these findings, we have clarified that 5-HT expression is increased in”
BackgroundAn irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835
The enteric nervous system and gastrointestinal innervation: integrated local and central control
Furness, J. B., Callaghan, B. P., Rivera, L. R., & Cho, H.-J. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_3 · Cited by 827
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728
Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility
Muller, P. A., Koscsó, B., Rajani, G. M., Stevanovic, K., Berres, M.-L., Hashimoto, D., Mortha, A., Leboeuf, M., Li, X.-M., Mucida, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.050 · Cited by 727
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699
A HORMONE MECHANISM FOR GALL-BLADDER CONTRACTION AND EVACUATION
Ivy, A. C., & Oldberg, E. (1928) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1928.86.3.599 · Cited by 691
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Saulnier, D. M., Riehle, K., Mistretta, T., Diaz, M., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., Milosavljevic, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.072 · Cited by 672
Tap, J., Derrien, M., Törnblom, H., Brazeilles, R., Cools-Portier, S., Doré, J., Störsrud, S., Le Nevé, B., Öhman, L., & Simrén, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.049 · Cited by 642
Review article: short chain fatty acids in health and disease
Cook, & Sellin (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00337.x · Cited by 619
Microbial endocrinology: the interplay between the microbiota and the endocrine system
Neuman, H., Debelius, J. W., Knight, R., & Koren, O. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuu010 · Cited by 613
Edfalk, S., Steneberg, P., & Edlund, H. (2008) · Diabetes · doi:10.2337/db08-0307 · Cited by 587
Nøhr, M. K., Pedersen, M. H., Gille, A., Egerod, K. L., Engelstoft, M. S., Husted, A. S., Sichlau, R. M., Grunddal, K. V., Seier Poulsen, S., Han, S., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1142 · Cited by 578
Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in Rats
Soret, R., Chevalier, J., De Coppet, P., Poupeau, G., Derkinderen, P., Segain, J. P., & Neunlist, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.053 · Cited by 530
De Palma, G., Lynch, M. D. J., Lu, J., Dang, V. T., Deng, Y., Jury, J., Umeh, G., Miranda, P. M., Pigrau Pastor, M., Sidani, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6397 · Cited by 505
Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes
Dunlop, S. P., Hebden, J., Campbell, E., Naesdal, J., Olbe, L., Perkins, A. C., & Spiller, R. C. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00672.x · Cited by 476
tana, C., umesaki, Y., imaoka, A., handa, T., kanazawa, M., & fukudo, S. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01427.x · Cited by 474
IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration
Deng, B., Wehling-Henricks, M., Villalta, S. A., Wang, Y., & Tidball, J. G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103180 · Cited by 472 · cited 1×
“On the other hand, Th2 cytokines including IL-10 may inhibit the expression of the above cytokines, thus accelerating of GI motility.(152,154) In IBS, it is still unclear whether these cytokines simply show this pattern of interaction.”
BackgroundShort-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats
Fukumoto, S., Tatewaki, M., Yamada, T., Fujimiya, M., Mantyh, C., Voss, M., Eubanks, S., Harris, M., Pappas, T. N., & Takahashi, T. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00442.2002 · Cited by 465 · cited 1×
“Histological studies have clarified that GPR43 is coexpressed with 5-HT,(114) and that SCFAs stimulate the release of 5-HT by EC cells in the colonic mucosa.(115) On the other hand, GPR40 and/or GPR120 are co-localized in cells expressing GIP, GLP-1, PYY, CCK, ghrelin, or 5HT,(116-118) although their ligands are predo…”
BackgroundKaraki, S.-I., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J. B., & Kuwahara, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0140-x · Cited by 460
Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice
Kashyap, P. C., Marcobal, A., Ursell, L. K., Larauche, M., Duboc, H., Earle, K. A., Sonnenburg, E. D., Ferreyra, J. A., Higginbottom, S. K., Million, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.047 · Cited by 451 · cited 1×
“In addition, Kashyap et al(166) have clarified that colonization of GF mice with gut microbiota from humans or mice can significantly shorten the GI transit time and that this effect is partially inhibited by 5-HT receptor antagonist.(166) These findings strongly indicate that 5-HT induced by microbiota stimuli play a…”
BackgroundSCFAs strongly stimulate PYY production in human enteroendocrine cells
Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F. M., Reimann, F., & Blottiere, H. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18259-0 · Cited by 450
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Johnsen, P. H., Hilpüsch, F., Cavanagh, J. P., Leikanger, I. S., Kolstad, C., Valle, P. C., & Goll, R. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30338-2 · Cited by 437
Microbial butyrate and its role for barrier function in the gastrointestinal tract
Plöger, S., Stumpff, F., Penner, G. B., Schulzke, J., Gäbel, G., Martens, H., Shen, Z., Günzel, D., & Aschenbach, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06553.x · Cited by 435
Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., & Ringel, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01891.x · Cited by 425
Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling
Anitha, M., Vijay–Kumar, M., Sitaraman, S. V., Gewirtz, A. T., & Srinivasan, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.034 · Cited by 397 · cited 1×
“The link between microbiota and the ENS has been demonstrated in GF mice, which show a reduced number of enteric neurons and associated deficits of gut motility,(140) whereas reconstitution of GF mice with conventional microbiota normalizes the density of the ENS network and, subsequently, gut physiology.(141) How, th…”
BackgroundMicrobial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
Wichmann, A., Allahyar, A., Greiner, T. U., Plovier, H., Lundén, G. Ö., Larsson, T., Drucker, D. J., Delzenne, N. M., Cani, P. D., & Bäckhed, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.012 · Cited by 380
Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats
Smith, G. P., Jerome, C., & Norgren, R. (1985) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1985.249.5.r638 · Cited by 372
Short chain fatty acids and their receptors: new metabolic targets
Layden, B. T., Angueira, A. R., Brodsky, M., Durai, V., & Lowe, W. L. (2013) · Translational Research · doi:10.1016/j.trsl.2012.10.007 · Cited by 357
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C., Singh, G., Marsden, C. A., & Spiller, R. C. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00726-8 · Cited by 356
Suzuki, T., Yoshida, S., & Hara, H. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508888733 · Cited by 355
Atkinson, W., Lockhart, S., Whorwell, P. J., Keevil, B., & Houghton, L. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.09.031 · Cited by 355 · cited 2×
“When IBS patients are subdivided, the plasma serotonin level is decreased in those with IBS-C(89,90) and increased in those with IBS-D.(90,91) A few histological studies have demonstrated that the number of 5-HT-positive cells is increased in IBS (especially post-infectious IBS),(89,92) although conflicting data have…”
Influence of ghrelin on interdigestive gastrointestinal motility in humans
Tack, J., Depoortere, I., Bisschops, R., Delporte, C., Coulie, B., Meulemans, A., Janssens, J., & Peeters, T. (2006) · Gut · doi:10.1136/gut.2004.060426 · Cited by 348
Ghrelin Induces Fasted Motor Activity of the Gastrointestinal Tract in Conscious Fed Rats
Fujino, K., Inui, A., Asakawa, A., Kihara, N., Fujimura, M., & Fujimiya, M. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.040600 · Cited by 340
Jalanka-Tuovinen, J., Salojärvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F. M., Zaitoun, A., Palva, A., Spiller, R. C., & de Vos, W. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305994 · Cited by 340
The Intestinal Microenvironment and Functional Gastrointestinal Disorders
Barbara, G., Feinle-Bisset, C., Ghoshal, U. C., Santos, J., Vanner, S. J., Vergnolle, N., Zoetendal, E. G., & Quigley, E. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.028 · Cited by 335 · cited 8×
“The present review provides a broad outline of interactions between the gut microbiota and gut hormone axis in relation to GI motility in the pathophysiology of FGIDs.”
BackgroundInfluentialLocalization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract
Wade, P., Chen, J., Jaffe, B., Kassem, I., Blakely, R., & Gershon, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02352.1996 · Cited by 328
Pozuelo, M., Panda, S., Santiago, A., Mendez, S., Accarino, A., Santos, J., Guarner, F., Azpiroz, F., & Manichanh, C. (2015) · Scientific Reports · doi:10.1038/srep12693 · Cited by 325
Parker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M., & Reimann, F. (2009) · Diabetologia · doi:10.1007/s00125-008-1202-x · Cited by 324
Irritable bowel syndrome—post salmonella infection
McKendrick, M. W., & Read, N. W. (1994) · Journal of Infection · doi:10.1016/s0163-4453(94)94871-2 · Cited by 320
The role of mast cells in functional GI disorders
Wouters, M. M., Vicario, M., & Santos, J. (2016) · Gut · doi:10.1136/gutjnl-2015-309151 · Cited by 308 · cited 3×
“Mast cells are able to release histamine, serotonin, tryptase, and prostaglandins, and these mediators may act on their specific receptors on myenteric neural cells, leading to altered motor function.(155) Recent evidence has emphasized the pivotal roles of macrophages in GI motility through their action on myenteric…”
BackgroundKrogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L., Mäkivuokko, H., Kajander, K., & Palva, A. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-95 · Cited by 308
Carroll, I. M., Ringel-Kulka, T., Keku, T. O., Chang, Y.-H., Packey, C. D., Sartor, R. B., & Ringel, Y. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00154.2011 · Cited by 292
Casén, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13236 · Cited by 289
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
Camilleri, M., Atanasova, E., Carlson, P. J., Ahmad, U., Kim, H. J., Viramontes, B. E., Mckinzie, S., & Urrutia, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34780 · Cited by 285
Liou, A. P., Lu, X., Sei, Y., Zhao, X., Pechhold, S., Carrero, R. J., Raybould, H. E., & Wank, S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.012 · Cited by 280
Crouzet, L., Gaultier, E., Del'Homme, C., Cartier, C., Delmas, E., Dapoigny, M., Fioramonti, J., & Bernalier‐Donadille, A. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12103 · Cited by 280 · cited 1×
“This is supported by experimental evidence that germ-free (GF) animals given microbiota transplants from IBS patients show visceral hypersensitivity and GI dysmotility.(131,132) On the other hand, although stress events in early life are closely associated with IBS development, the gut microbiota profile may be possib…”
BackgroundCholecystokinin—From Local Gut Hormone to Ubiquitous Messenger
Rehfeld, J. F. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00047 · Cited by 265
Yeo, A., Boyd, P., Lumsden, S., Saunders, T., Handley, A., Stubbins, M., Knaggs, A., Asquith, S., Taylor, I., Bahari, B., et al. (2004) · Gut · doi:10.1136/gut.2003.035451 · Cited by 255
Liu, H.-N., Wu, H., Chen, Y.-Z., Chen, Y.-J., Shen, X.-Z., & Liu, T.-T. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.142 · Cited by 254
Serotonin Skews Human Macrophage Polarization through HTR2B and HTR7
de las Casas-Engel, M., Domínguez-Soto, A., Sierra-Filardi, E., Bragado, R., Nieto, C., Puig-Kroger, A., Samaniego, R., Loza, M., Corcuera, M. T., Gómez-Aguado, F., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201133 · Cited by 251
A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
Codling, C., O’Mahony, L., Shanahan, F., Quigley, E. M. M., & Marchesi, J. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0934-x · Cited by 243
G-Protein-Coupled Receptors in Intestinal Chemosensation
Reimann, F., Tolhurst, G., & Gribble, F. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.019 · Cited by 236
Cremon, C., Carini, G., Wang, B., Vasina, V., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Grundy, D., Tonini, M., De Ponti, F., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.86 · Cited by 223 · cited 1×
“from the colonic mucosa correlated with the severity of abdominal pain in IBS patients.(92)”
BackgroundTalley, N. J., Verlinden, M., Snape, W., Beker, J. A., Ducrotte, P., Dettmer, A., Brinkhoff, H., Eaker, E., Ohning, G., Miner, P. B., et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00868.x · Cited by 222
Iyer, L. M., Aravind, L., Coon, S. L., Klein, D. C., & Koonin, E. V. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.05.007 · Cited by 217
The immune system in irritable bowel syndrome
Barbara, G., Cremon, C., Carini, G., Bellacosa, L., Zecchi, L., Giorgio, R. D., Corinaldesi, R., & Stanghellini, V. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.4.349 · Cited by 211 · cited 1×
“Among the various immune cells, mast cells have been highlighted in the pathophysiology of IBS as their numbers are increased in colonic tissues of affected patients, and this increase is correlated with the severity of the clinical symptoms.(155,156) Mast cells are able to release histamine, serotonin, tryptase, and…”
BackgroundCarroll, I. M., Chang, Y.-H., Park, J., Sartor, R. B., & Ringel, Y. (2010) · Gut Pathogens · doi:10.1186/1757-4749-2-19 · Cited by 203
Parkes, G. C., Rayment, N. B., Hudspith, B. N., Petrovska, L., Lomer, M. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01803.x · Cited by 200
The L-cell in nutritional sensing and the regulation of appetite
Spreckley, E. (2015) · Frontiers in Nutrition · doi:10.3389/fnut.2015.00023 · Cited by 198
Systematic review with meta‐analysis: post‐infectious functional dyspepsia
Futagami, S., Itoh, T., & Sakamoto, C. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13006 · Cited by 198
Zhuang, X., Xiong, L., Li, L., Li, M., & Chen, M. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13471 · Cited by 188
Serotonin and GI Disorders: An Update on Clinical and Experimental Studies
Manocha, M., & Khan, W. I. (2012) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2012.8 · Cited by 184
Zhao, A., Urban, J. F., Anthony, R. M., Sun, R., Stiltz, J., van Rooijen, N., Wynn, T. A., Gause, W. C., & Shea-Donohue, T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.077 · Cited by 181
Houghton, L. A., Atkinson, W., Whitaker, R. P., Whorwell, P. J., & Rimmer, M. J. (2003) · Gut · doi:10.1136/gut.52.5.663 · Cited by 178
Short-Chain Fatty Acid Receptor and Its Contribution to Glucagon-Like Peptide-1 Release
Kaji, I., Karaki, S.-I., & Kuwahara, A. (2014) · Digestion · doi:10.1159/000356211 · Cited by 177 · cited 1×
“Therefore, it had been expected that SCFA would promote GLP-1 and PYY secretion by activating these GPRs, and indeed several in vivo studies have demonstrated that intraluminal injection of SCFAs induced the release of PYY and GLP-1 into the circulating blood.(110) Furthermore, in vitro studies have shown that activat…”
BackgroundChapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171
The role of microbial endocrinology in infectious disease
Lyte, M. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1370343 · Cited by 168
Lopetuso, L. R., Petito, V., Graziani, C., Schiavoni, E., Paroni Sterbini, F., Poscia, A., Gaetani, E., Franceschi, F., Cammarota, G., Sanguinetti, M., et al. (2018) · Digestive Diseases · doi:10.1159/000477205 · Cited by 168
Shukla, R., Ghoshal, U., Dhole, T. N., & Ghoshal, U. C. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3607-y · Cited by 166
Sundin, J., Rangel, I., Fuentes, S., Heikamp‐de Jong, I., Hultgren‐Hörnquist, E., de Vos, W. M., & Brummer, R. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13055 · Cited by 164
Pharmacology of serotonin: what a clinician should know
De Ponti, F. (2004) · Gut · doi:10.1136/gut.2003.035568 · Cited by 159
Antibiotic use, childhood affluence and irritable bowel syndrome (IBS)
Mendall, M. A., & Kumar, D. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199801000-00011 · Cited by 155
Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons
Edholm, T., Levin, F., Hellström, P. M., & Schmidt, P. T. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.04.001 · Cited by 154
Faure, C., Patey, N., Gauthier, C., Brooks, E. M., & Mawe, G. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.032 · Cited by 154
Exploring and Understanding the Biochemical Diversity of the Human Microbiota
Koppel, N., & Balskus, E. P. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.12.008 · Cited by 154
Rangel, I., Sundin, J., Fuentes, S., Repsilber, D., de Vos, W. M., & Brummer, R. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13399 · Cited by 151
Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?
Hughes, P. A., Zola, H., Penttila, I. A., Blackshaw, A. L., Andrews, J. M., & Krumbiegel, D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.120 · Cited by 148
Intestinal permeability and irritable bowel syndrome
Camilleri, M., & Gorman, H. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00925.x · Cited by 145
Pathophysiology and Treatment of Functional Dyspepsia
Tack, J., & Lee, K. J. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156109.97999.d1 · Cited by 143
manabe, N., wong, B. S., camilleri, M., burton, D., mckinzie, S., & zinsmeister, A. R. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01442.x · Cited by 142
Pilichiewicz, A. N., Feltrin, K. L., Horowitz, M., Holtmann, G., Wishart, J. M., Jones, K. L., Talley, N. J., & Feinle-Bisset, C. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02041.x · Cited by 141
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research · doi:10.1155/2011/279530 · Cited by 138
Igarashi, M., Nakae, H., Matsuoka, T., Takahashi, S., Hisada, T., Tomita, J., & Koga, Y. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000144 · Cited by 133
Microbial regulation of GLP-1 and L-cell biology
Greiner, T. U., & Bäckhed, F. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.012 · Cited by 131
Shindo, T., Futagami, S., Hiratsuka, T., Horie, A., Hamamoto, T., Ueki, N., Kusunoki, M., Miyake, K., Gudis, K., Tsukui, T., et al. (2009) · Digestion · doi:10.1159/000205740 · Cited by 126
Amato, A., Cinci, L., Rotondo, A., Serio, R., Faussone-pellegrini, M. S., Vannucchi, M. G., & Mulè, F. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01476.x · Cited by 124 · cited 1×
“Moreover, recent evidence has suggested that GLP-1 inhibits postprandial GI motility through the GLP1 receptor at myenteric neurons, involving nitrergic and cAMPdependent mechanisms.(27,28) Peptide YY”
BackgroundKerckhoffs, A. P. M., Ben-Amor, K., Samsom, M., van der Rest, M. E., de Vogel, J., Knol, J., & Akkermans, L. M. A. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.022848-0 · Cited by 124
Hormones of the gut–brain axis as targets for the treatment of upper gastrointestinal disorders
Sanger, G. J., & Lee, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2444 · Cited by 122
Desachy, A., Clavel, M., Vuagnat, A., Normand, S., Gissot, V., & François, B. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0983-6 · Cited by 122
MCCALLUM, R. W., CYNSHI, O., & INVESTIGATIVE TEAM (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03461.x · Cited by 118
MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat
Türler, A., Schwarz, N. T., Türler, E., Kalff, J. C., & Bauer, A. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2001 · Cited by 117
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype
Mearin, F., Balboa, A., Badía, X., Baró, E., Caldwell, E., Cucala, M., Díaz-Rubio, M., Fueyo, A., Ponce, J., Roset, M., et al. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200302000-00010 · Cited by 115
Serotonin and colonic motility
Kendig, D. M., & Grider, J. R. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12617 · Cited by 113
Beatty, J. K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3976 · Cited by 108
Giamarellos-Bourboulis, E., Tang, J., Pyleris, E., Pistiki, A., Barbatzas, C., Brown, J., Lee, C. C., Harkins, T. T., Kim, G., Weitsman, S., et al. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1027261 · Cited by 106
Mearin, F., Baró, E., Roset, M., Badía, X., Zárate, N., & Pérez, I. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04023.x · Cited by 106
Gastric emptying in rats: role of afferent neurons and cholecystokinin
Forster, E. R., Green, T., Elliot, M., Bremner, A. J., & Dockray, G. J. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.258.4.g552 · Cited by 102
Halim, M. A., Degerblad, M., Sundbom, M., Karlbom, U., Holst, J. J., Webb, D.-L., & Hellström, P. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02006 · Cited by 102
Chung, C.-S., Chang, P.-F., Liao, C.-H., Lee, T.-H., Chen, Y., Lee, Y.-C., Wu, M.-S., Wang, H.-P., & Ni, Y.-H. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1116107 · Cited by 101
Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils
Suzuki, H., Masaoka, T., Hosoda, H., Ota, T., Minegishi, Y., Nomura, S., Kangawa, K., & Ishii, H. (2004) · Gut · doi:10.1136/gut.2003.021568 · Cited by 100
Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats
Li, Y., & Owyang, C. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90180-5 · Cited by 99
Gobert, A. P., Sagrestani, G., Delmas, E., Wilson, K. T., Verriere, T. G., Dapoigny, M., Del’homme, C., & Bernalier-Donadille, A. (2016) · Scientific Reports · doi:10.1038/srep39399 · Cited by 98
Is irritable bowel syndrome an organic disorder?
El-Salhy, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.384 · Cited by 95
DIZDAR, V., SPILLER, R., SINGH, G., HANEVIK, K., GILJA, O. H., EL‐SALHY, M., & HAUSKEN, T. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04251.x · Cited by 94
HELLSTRÖM, P. M., HEIN, J., BYTZER, P., BJÖRNSSÖN, E., KRISTENSEN, J., & SCHAMBYE, H. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03870.x · Cited by 91
Alterations in serotonin metabolism in the irritable bowel syndrome
Thijssen, A. Y., Mujagic, Z., Jonkers, D. M. A. E., Ludidi, S., Keszthelyi, D., Hesselink, M. A., Clemens, C. H. M., Conchillo, J. M., Kruimel, J. W., & Masclee, A. A. M. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13459 · Cited by 87
Akamizu, T., Iwakura, H., Ariyasu, H., Hosoda, H., Murayama, T., Yokode, M., Teramukai, S., Seno, H., Chiba, T., Noma, S., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0768 · Cited by 86
Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt
Nakae, H., Tsuda, A., Matsuoka, T., Mine, T., & Koga, Y. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000109 · Cited by 86
Preston, D. M., Adrian, T. E., Christofides, N. D., Lennard-Jones, J. E., & Bloom, S. R. (1985) · Gut · doi:10.1136/gut.26.10.1059 · Cited by 84
Mechanisms of smooth muscle responses to inflammation
Shea‐Donohue, T., Notari, L., Sun, R., & Zhao, A. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01986.x · Cited by 80
Disturbed Motilin and Cholecystokinin Release in the Irritable Bowel Syndrome
Sjölund, K., Ekman, R., Lindgren, S., & Rehfeld, J. F. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609036895 · Cited by 80
Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man
Witte, A.-B., Grybäck, P., Holst, J. J., Hilsted, L., Hellström, P. M., Jacobsson, H., & Schmidt, P. T. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.07.013 · Cited by 80
Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification
Suzuki, H., Nishizawa, T., & Hibi∥, T. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1847-5 · Cited by 79
Zeber-Lubecka, N., Kulecka, M., Ambrozkiewicz, F., Paziewska, A., Goryca, K., Karczmarski, J., Rubel, T., Wojtowicz, W., Mlynarz, P., Marczak, L., et al. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1215805 · Cited by 78
Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility
Cipriani, G., Gibbons, S. J., Kashyap, P. C., & Farrugia, G. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.01.003 · Cited by 77
Tough, I., Forbes, S., Tolhurst, R., Ellis, M., Herzog, H., Bornstein, J., & Cox, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01401.x · Cited by 74
Kumar, S., Ranjan, P., Mittal, B., & Ghoshal, U. C. (2012) · PubMed · Cited by 72
Kendrick, K., Leng, G., & Higuchi, T. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00255.x · Cited by 71
Shinomiya, T., Fukunaga, M., Akamizu, T., Irako, T., Yokode, M., Kangawa, K., Nakai, Y., & Nakai, Y. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510015403 · Cited by 69
El-Salhy, M., Gundersen, D., Østgaard, H., Lomholt-Beck, B., Hatlebakk, J. G., & Hausken, T. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1948-8 · Cited by 66
Lee, K. J., Cha, D. Y., Cheon, S. J., Yeo, M., & Cho, S. W. (2009) · Digestion · doi:10.1159/000215389 · Cited by 62
Takamori, K.-I., Mizuta, Y., Takeshima, F., Akazawa, Y., Isomoto, H., Ohnita, K., Ohba, K., Omagari, K., Shikuwa, S., & Kohno, S. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225614.94470.47 · Cited by 58
Maccaferri, S., Candela, M., Turroni, S., Centanni, M., Severgnini, M., Consolandi, C., Cavina, P., & Brigidi, P. (2012) · Gut Microbes · doi:10.4161/gmic.21009 · Cited by 57
Abnormal rectal endocrine cells in patients with irritable bowel syndrome
El‐Salhy, M., Gundersen, D., Hatlebakk, J. G., Gilja, O. H., & Hausken, T. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.11.005 · Cited by 55
The metabolic role of GIP: physiology and pathology
Morgan, L. M. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240585 · Cited by 55
Ghrelin in patients with irritable bowel syndrome
El-Salhy (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000183 · Cited by 53
Genetics and Genotypes in Irritable Bowel Syndrome: Implications for Diagnosis and Treatment
Park, M. I., & Camilleri, M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.009 · Cited by 52
Yang, M., Fukui, H., Eda, H., Xu, X., Kitayama, Y., Hara, K., Kodani, M., Tomita, T., Oshima, T., Watari, J., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00232.2016 · Cited by 52
Self-citationCamilleri, M., Vazquez-Roque, M., Iturrino, J., Boldingh, A., Burton, D., McKinzie, S., Wong, B. S., Rao, A. S., Kenny, E., Månsson, M., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2012 · Cited by 50
Asian Motility Studies in Irritable Bowel Syndrome
Lee, O. Y. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.2.120 · Cited by 49
Miyano, Y., Sakata, I., Kuroda, K., Aizawa, S., Tanaka, T., Jogahara, T., Kurotani, R., & Sakai, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064777 · Cited by 49
Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle
Amato, A., Baldassano, S., Liotta, R., Serio, R., & Mulè, F. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0525 · Cited by 48
Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats
Gülpinar, M. A., Bozkurt, A., Coşkun, T., Ulusoy, N. B., & Yeǧen, B. Ç. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g924 · Cited by 48
Ghrelin increases vagally mediated gastric activity by central sites of action
Swartz, E. M., Browning, K. N., Travagli, R. A., & Holmes, G. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12261 · Cited by 46
Sigmoid‐colonic motility in health and irritable bowel syndrome: a role for 5‐hydroxytryptamine
Houghton, L. A., Atkinson, W., Lockhart, S., Fell, C., Whorwell, P. J., & Keevil, B. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00943.x · Cited by 46
Brennan, I. M., Little, T. J., Feltrin, K. L., Smout, A. J. P. M., Wishart, J. M., Horowitz, M., & Feinle-Bisset, C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90791.2008 · Cited by 45
Yusof, N., Hamid, N., Feei, Z., Lawenko, R. M., Mohammad, W. M. Z. W., Collins, D. A., Liong, M. T., Odamaki, T., Xiao, J., & Lee, Y. Y. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0224-7 · Cited by 45
Bharucha, A. E., Camilleri, M., Burton, D. D., Thieke, S. L., Feuerhak, K. J., Basu, A., & Zinsmeister, A. R. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.330 · Cited by 44
Chapman, M. J., Deane, A. M., O’Connor, S. L., Nguyen, N. Q., Fraser, R. J., Richards, D. B., Hacquoil, K. E., Johnson, L. S. V., Barton, M. E., & Dukes, G. E. (2016) · Critical Care · doi:10.1186/s13054-016-1420-4 · Cited by 44
Li, Z., Zhang, N., Wen, S., Zhang, J., Sun, X., Fan, X., & Sun, Y. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.12.007 · Cited by 44
Endocrine cells in the ileum of patients with irritable bowel syndrome
El‐Salhy, M., Gilja, O. H., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2383 · Cited by 43
Beginnings: A reflection on the history of gastrointestinal endocrinology
Rehfeld, J. F. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.05.087 · Cited by 40
Nakade, Y., Tsukamoto, K., Iwa, M., Pappas, T. N., & Takahashi, T. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.06.007 · Cited by 38
Proximal and distal gut hormone secretion in irritable bowel syndrome
Van Der Veek, P. P. J., Biemond, I., & Masclee, A. A. M. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500206210 · Cited by 38
Boyer, J., Saint‐Paul, M., Dadone‐Montaudié, B., Patouraux, S., Vivinus, M., Ouvrier, D., Michiels, J., Piche, T., & Tulić, M. K. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13223 · Cited by 38
Rapid Gastric Emptying in Patients With Functional Diarrhea
Charles, F., Phillips, S. F., Camilleri, M., & Thomforde, G. M. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.4.323 · Cited by 37
Uusijärvi, A., Bergström, A., Simrén, M., Ludvigsson, J. F., Kull, I., Wickman, M., Alm, J., & Olén, O. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12340 · Cited by 37
Yang, M., Fukui, H., Eda, H., Kitayama, Y., Hara, K., Kodani, M., Tomita, T., Oshima, T., Watari, J., & Miwa, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6955 · Cited by 36
Self-citationCholecystokinin Hyperresponsiveness in Dysmotility‐Type Nonulcer Dyspepsia
Chua, A., Dinan, T. G., Rovati, L. C., & Keeling, P. W. N. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44077.x · Cited by 35
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study
Stasi, C., Bellini, M., Gambaccini, D., Duranti, E., de Bortoli, N., Fani, B., Albano, E., Russo, S., Sudano, I., Laffi, G., et al. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16155 · Cited by 35
High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome
Simrén, M., Björnsson, E. S., & Abrahamsson, H. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00582.x · Cited by 34
Effect of erythromycin on the oro-caecal transit time in man
Lehtola, J., Jauhonen, P., Kes�niemi, A., Wikberg, R., & Gordin, A. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316094 · Cited by 33
Toyoshima, F., Oshima, T., Nakajima, S., Sakùrai, J., Tanaka, J., Tomita, T., Hori, K., Matsumoto, T., & Miwa, H. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-88 · Cited by 32
Self-citationStudy of the activated macrophage transcriptome
Novoselov, V. V., Sazonova, M. A., Ivanova, E. A., & Orekhov, A. N. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.09.014 · Cited by 31
WENDELBO, I. H., Mazzawi, T. R. E., & El‐Salhy, M. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1784 · Cited by 30
Levosulpirida en el manejo de la dispepsia funcional y la gastroparesia
Serra, J. (2010) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2010.07.002 · Cited by 30
New motilin agonists: a long and winding road
Peeters, T. L. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00749.x · Cited by 30
Sansone, R. A., & Sansone, L. A. (2015) · Europe PMC (PubMed Central) · Cited by 30
El‐Salhy, M., Hatlebakk, J. G., & Hausken, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i32.9577 · Cited by 29
El‐Salhy, M., & Gilja, O. H. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0643-4 · Cited by 29
Little, T. J., Gopinath, A., Patel, E., Mcglone, A., Lassman, D. J., D’amato, M., Mclaughlin, J. T., & Thompson, D. G. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01552.x · Cited by 28
Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia
Mujakovic, S., Linde, J. J. M. T., de Wit, N. J., van Marrewijk, C. J., Fransen, G. A. J., Onland‐Moret, N. C., Laheij, R. J. F., Muris, J. W. M., Grobbee, D. E., Samsom, M., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-140 · Cited by 27
Landry, C., Vidon, N., Sogni, P., Nepveux, P., Chaumeil, J. C., Chauvin, J., Couturier, D., & Chaussade, S. (1995) · PubMed · Cited by 26
Yang, Y., Cui, X., Chen, Y., Wang, Y., Li, X., Lin, L., & Zhang, H. (2014) · PubMed · Cited by 25
van der Schaar, P. J., van Hoboken, E., Ludidi, S., & Masclee, A. (2012) · Colorectal Disease · doi:10.1111/codi.12034 · Cited by 24
Ayachi, S. E., Borie, F., Magous, R., Sasaki, K., Le Nguyen, D., Bali, J. ‐., Millat, B., & Jarrousse, C. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00628.x · Cited by 24
Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia.
Cheung, C. K. Y., Lee, Y.-Y., Chan, Y., Cheong, P., Law, W. T., Lee, S.-F. E., Sung, J. J. Y., Chan, F., & Wu, J. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.026 · Cited by 23
Lin, H. C., Zaidel, O., & Hum, S. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020179009559 · Cited by 22
Stomach antral endocrine cells in patients with irritable bowel syndrome
EL-SALHY, M., GILJA, O. H., HATLEBAKK, J. G., & HAUSKEN, T. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1887 · Cited by 22
Changes in serum ghrelin level in relation to meal‐time in patients with functional dyspepsia
Kazemi, M., Eshraghian, A., Hamidpour, L., & Taghavi, S. A. (2014) · United European Gastroenterology Journal · doi:10.1177/2050640614563373 · Cited by 19
Research works printed but not linked: 3
- Sansone RA Sansone LA Irritable bowel syndrome: relationships with abuse in childhood Innov Clin Neurosci 2015 12 34 37 26155376 PMC4479362
- Kabouridis PS Lasrado R McCallum S Gut microbial products regulate murine gastrointestinal motility via toll-like receptor 4 signaling Gastroenterology 2012 143 1006 1016 e4 10.1053/j.gastro.2012.06.034 22732731 PMC3458182 · DOI · Paper page
- Brun P Giron MC Qesari M Exploring and understanding the biochemical diversity of the human microbiota Cell Chem Biol 2016 23 18 30 10.1016/j.chembiol.2015.12.008 26933733 · DOI
Cited by
Sex differences in gut microbiota
Kim, Y. S., Unno, T., Kim, B.-Y., & Park, M.-S. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.190009 · Cited by 610
“Because the gut microbiota maintains homeostasis of the host and has functions in immunity and metabolism, the perturbated microbiota (dysbiosis) is associated with not only GI diseases but also other diseases such as cancers, metabolic diseases, allergies, and immunologic disorders [3,4].”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
Salliss, M. E., Farland, L. V., Mahnert, N. D., & Herbst-Kralovetz, M. M. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab035 · Cited by 274
How biological sex of the host shapes its gut microbiota
Valeri, F., & Endres, K. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100912 · Cited by 264
Probiotics: Reiterating What They Are and What They Are Not
Reid, G., Gadir, A. A., & Dhir, R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00424 · Cited by 184
Metadata
- Authors
- Fukui, H., Xu, X., & Miwa, H.
- Affiliations
- Hyogo Medical University (JP)
- Corresponding author
- Fukui, Hirokazu
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2018-07-30
- Volume
- 24
- Issue
- 3
- Pages
- 367-386
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC6034676
- OpenAlex
- W2811358806
- Cited by
- 128
- References
- 212
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 15 · 2023: 22 · 2022: 17 · 2021: 15 · 2020: 11 · 2019: 13 · 2018: 3
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- gut microbiota, gastrointestinal hormones, functional gastrointestinal disorders, gastrointestinal motility, short-chain fatty acids, enteroendocrine cells, enteric nervous system, inflammatory signaling, gut-brain axis, pathophysiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.